Nomura Holdings Inc Gossamer Bio, Inc. Transaction History

Nomura Holdings Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.51 - $1.27 $20,400 - $50,800	40,000 New	40,000 $36,000
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $592,000 - $721,500	-74,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.63 - $10.94 $72,492 - $91,896	-8,400 Reduced 10.19%	74,000 $684,000
Q4 2020 Feb 16, 2021	BUY	$8.3 - $13.59 $43,168 - $70,681	5,201 Added 6.74%	82,400 $800,000
Q3 2020 Nov 12, 2020	BUY	$11.3 - $14.75 $872,348 - $1.14 Million	77,199 New	77,199 $951,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $93M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.